Company
Syndex Bio
Like PCR, but for methylation
Also known as SYNDEX BIO INC.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Foxton, Cambridge, United Kingdom
- Founded
- 2022
- Legal name
- SYNDEX BIO INC.
Claim, correct or request removal
Record updated 28 September 2026
About
mcPCR is our novel and proprietary platform technology that preserves DNA methylation during DNA amplification.
Funding snapshot
- Total raised
- $15.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Seed, $15.5M2026-02-23
Funding rounds
- Seed
- $15.5M2026-02-23, Company stated
- Round, 2025
- $15.5M2025-02-27, SEC form D sold, 12 investors
Products
- Other
- mcPCR
Loading relationship preview